866-997-4948 (US-Canada Toll Free)

China Research and Intelligence Co., Ltd. (CRI) is engaged in market research in many industrial fields such as pharmaceuticals, automobiles, manufacture and consumer goods. CRI also provide feasibiltiy study, survey, interviews, etc. in China. CRI is always aiming to deliver success to clients.

Show More

China Research and Intelligence Co., Ltd. (CRI) is engaged in market research in many industrial fields such as pharmaceuticals, automobiles, manufacture and consumer goods. CRI also provide feasibiltiy study, survey, interviews, etc. in China. CRI is always aiming to deliver success to clients.

Show Less
  • Investigation Report on China Ossotide Market, 2010-2019

    Jun 2015

    By

    Pages

    According to statistics, the incidence of rheumatoid arthritis (RA) is 0.2%-0.36% and the number of cases is 5-10 million in China. Apart from RA, osteoarthritis, an expression of degraded joint function, is also common to see. With the ageing population in China, over 60% of elder people aged above 60 suffer from osteoarthritis, says a study. Patients with osteoarthritis typically show...

    USD 2000View Report
  • Investigation Report on China Levothyroxine Market, 2010-2019

    Jun 2015

    By

    Pages

    Thyroid hormones (TH) have the greatest effect of promoting growth on five-month-old babies or younger ones. Without thyroid hormones mainly promote the growth and development of bones, brain and reproductive organs, even the growth hormone (GH) of pipuitary gland can’t work. Besides, pipuitary gland will produce less GH if there is a lack of thyroid hormones. Therefore, cretinism is...

    USD 2000View Report
  • Investigation Report on China Moxifloxacin Market, 2010-2019

    Jun 2015

    By

    Pages

    As the fourth generation of quinolones drugs, moxifloxacin (moxifloxacin hodrochloride) was first introduced to the market by The Bayer Group in Sep. 1999. It is utilized in the treatment of adult patients (aged 18 and above) diagnosed with upper and lower respiratory tract infections, e.g. acute sinusitis, acute exacerbation of chronic bronchitis (AECB), community-acquired pneumonia, and skin...

    USD 2000View Report
  • Investigation Report on China Ganglioside Market, 2010-2019

    Jun 2015

    By

    Pages

    Cardia-cerebrovascular disease is the first big disease with a mortality rate of 20% in the world and over 40% in China. Besides, as most cardia-cerebrovascular diseases are chronic diseases, long-term treatment is needed, which has forced the big market of cardia-cerebrovascular chemicals. As the major varieties of chemicals for the treatment of hypertension, hyperlipidemia and thrombusare...

    USD 2000View Report
  • Investigation Report on China Flurbiprofen Market, 2010-2019

    Jun 2015

    By

    Pages

    Non-steroidal anti-inflammatory drug (NSAID) has a totally different chemical structure from steroids which have a similar anti-inflammatory antirheumatic action. NSAID can also provide analgestic and antipyretic effects with fewer side effects compared with steroids. NSAID, be it nonprescription one or prescription one, has been the most widely used in the clinic. The market size of NSAID in...

    USD 2000View Report
  • Investigation Report on China Menotropins Market, 2010-2019

    Jun 2015

    By

    Pages

    According to the statistics, at present there are about 100 million women in the high-fertility period (aged 20-29) in China, over 12% of whom suffer from infertility. About 30% of female diagnosed with infertility suffer from ovulation inhibition. Herein it can be estimated that the number of potential patients suffering from ovulation inhibition is larger than 3.6 million. Popular clinic...

    USD 2000View Report
  • Investigation Report on China Salmon Calcitonin Market, 2010-2019

    Jun 2015

    By

    Pages

    China has become the country with the largest number of osteoporosis patients. A nationwide large-scale epidemiological survey has also shown that the incidence of osteoporosis in China has exceeded 12% and that this figure among elders is over 50%, among which nearly 33% suffer from fracture. Some experts forecast that the number of osteoporosis patients and patients with low bone mass will...

    USD 2000View Report
  • Investigation Report on China Progesterone Market, 2010-2019

    Jun 2015

    By

    Pages

    The clinical demand for steroid drug is increasing fast due to its wide application and good efficacy especially its extended use in regulating human endocrine and slowing down ageing in recent years. Progesterone, a natural progestogen produced by the corpus luteum, has significant morphological effects on endometrium stimulated by estrogen and is essential to supporting pregnancy. It...

    USD 2000View Report
  • Investigation Report on China Entecavir Market, 2010-2019

    Jun 2015

    By

    Pages

    The number of people infected with hepatitis B virus (HBV) exceeds 100 million in China, among which 20-30 million suffering from chronic Hepatitis B. About 0.5 million Chinese is estimated to die of liver damage and liver cancer caused by chronic Hepatitis B, causing a loss of over CNY100 billion for society. Entecavir, an oral drug of oral deoxyguanosine, was developed by...

    USD 2000View Report
  • Investigation Report on China Telmisartan Market, 2010-2019

    Jun 2015

    By

    Pages

    The number of hypertension patients in China is estimated to surpass 300 million with one in three adults suffering from it. Out of all the dyazides, angiotension receptor blocker (ARB) is among a new generation which grows fast. Ever since the appearance of losartan which has been first applied in the clinic, 8 kinds of similar drugs have come out for sale and there are also 5 kinds...

    USD 2000View Report
  • Investigation Report on China Glucosamine Market, 2010-2019

    Jun 2015

    By

    Pages

    Osteoarthritis (OA) is a kind of chronic degenerative disease, and it is also the commonest arthritis in the clinic. The lesion is a slow yet progressing process. Major symptoms include wearing away and damage of articular cartilage, whereas clinical symptoms include arthralgia, swelling of joint, joint deformity and limited mobility. The elderly are at high risk of osteoarthritis. About...

    USD 2000View Report
  • Investigation Report on China Rosuvastatin Market, 2010-2019

    Jun 2015

    By

    Pages

    First developed by Shionogi Inc. under the code name of S-4522 at the end of 1980s, rosuvastatin (rosuvastatin calcium) along with its development, marketing and sales rights, was transferred to AstraZeneca in Jun. 1998 under the code name of ZD-4522. On Nov.7, 2002, rosuvastatin got its first approval in the Netherlands and later it was approved by Health Council of Canada and FDA under the...

    USD 2000View Report
  • Investigation Report on China Doxofylline Market, 2010-2019

    Jun 2015

    By

    Pages

    With the climatic and environmental changes, seasonal asthma has become the main reason for respiratory ailments. According to an epidemiological survey, the incidence of respiratory ailments is 16% of the incidence of all diseases. About 280 million people in the world suffer from different degrees of seasonal asthma. The situation is more serious in industrialized countries and regions where...

    USD 2000View Report
  • Investigation Report on China Octreotide Market, 2010-2019

    Jun 2015

    By

    Pages

    Octreotide, an octapeptide that mimics natural somatostatin, has been widely used in clinic for the treatment of upper gastrointestinal variceal hemorrhage and stomach ulcer bleeding, acute pancreatitis, endocrine tumors. First approved to be sold in 1996, octreotide was developed by Novartis AG under the trade name of Sandostatin. The approved indications at that time were acromegaly,...

    USD 2000View Report
  • Investigation Report on China Edaravone Market, 2010-2019

    Jun 2015

    By

    Pages

    Cerebrovascular disease is one of the three principal diseases that can cause people to death. Acute cerebral infarction which occupies 70% of cerebrovascular disease has a disability rate of 50%-70% and a recurrence rate of 40%. And one thing to be noted is that the more relapses people have, the higher the mortality and disability. Acute cerebral infarction, one of the serious...

    USD 2000View Report
  • Investigation Report on China Atorvastatin Market, 2010-2019

    Jun 2015

    By

    Pages

    With the change of life styles brought about by the economic development and the rising incomes, the number of hyperlipidemia patients in China keeps growing, being estimated to reach 160-200 million in the near future. Atorvastatin, a common drug that can lower blood cholesterol levels, was developed by Pfizer under the trade name of Lipitor. Boasting of nearly 20 years of use in over...

    USD 2000View Report
  • Investigation Report on China Ezetimibe Market, 2010-2019

    Jun 2015

    By

    Pages

    With the sustained economic development and the improvements in diet, Chinese people’s blood fat level rises too. Many local epidemiological studies on blood fat have proved that a conservative estimate of the incidence of hyperlipemia is 7%-8% while the actual incidence might be above 10%. Over 100 million people in China have to receive cholesterol-lowering therapy, more so with the...

    USD 2000View Report
  • Investigation Report on China Methylprednisolone Market, 2010-2019

    Jun 2015

    By

    Pages

    Ever since the 1990s, steroid has entered its golden age with over 120 varieties being made for application and sales value in the global market increasing by 10%-15% each year. During the process of product restructuring and industrial development, steroid’s Active Pharmaceutical Ingredients (APIs) made in China take an important position in the global market. Out of all the varieties...

    USD 2000View Report
  • Investigation Report on China Desloratadine Market, 2010-2019

    Jun 2015

    By

    Pages

    Histamine, a substance which can lead to inflammation and anaphylaxis, is one of the important chemical mediators of immediate anaphylaxis (the most common type I allergy in clinic). The incidence of allergy has always been high and shows an increasing trend. According to the American Acadymy of Allergy, Asthma and Immunology, allergy has become the sixth chronic disease in the US with 20%-40%...

    USD 2000View Report
  • Investigation Report on China Budesonide Market, 2010-2019

    Jun 2015

    By

    Pages

    With the climatic and environmental changes, seasonal asthma has become the main reason for respiratory ailments. According to an epidemiological survey, the incidence of respiratory ailments is 16% of the incidence of all diseases. About 280 million people in the world suffer from different degrees of seasonal asthma, more so in industrialized countries and regions where tobacco consumption...

    USD 2000View Report
  • Investigation Report on China Celecoxib Market, 2010-2019

    Jun 2015

    By

    Pages

    Currently, there are over 30 million people around the world using non-steroidal anti-inflammatory drugs (NSAIDs) as anti-inflammatory pain-relief drugs. However, many drugs under the category of NSAIDs cause gastrointestinal adverse reactions such as ulcer, perforation and bleeding. The latest research has shown that among all the NSAIDs, celecoxib reports the lowest number of cases of...

    USD 2000View Report
  • Investigation Report on China Insulin Lispro Market, 2010-2019

    Jun 2015

    By

    Pages

    According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients has reached 382 million in the world, 80% of which come from middle income and low income countries and the figure demonstrates a fast rising trend. It is estimated that by 2035, there will be nearly 592 million...

    USD 2000View Report
  • Investigation Report on China Recombinant Factor Market, 2010-2019

    Jun 2015

    By

    Pages

    Hemophilia is a hereditary bleeding disorder caused by a lack of clotting factor or Ⅸ, though not rare, which affects mostly males. Hemophilia A (clotting factor deficiency) is the most common form of the disorder. The number of the cases of hemophilia is about over 0.4 million around the world while that in China is about 0.06-0.1 million, among which 80% lack clotting factor while over...

    USD 2000View Report
  • Investigation Report on China Tacrolimus Market, 2010-2019

    Jun 2015

    By

    Pages

    Tacrolimus (also FK506) is a macrolide lactone immunosuppressive drug discovered from a soil sample that contained the bacterium Streptomyces tsukubaensis in 1984 by Fujisawa Pharmaceutical Co., Ltd. Tacrolimus acts like cyclosporine and its systemic use is mainly for the prevention of allograft rejection and the treatment of immune disease. Different from cyclosporine, it can penetrate...

    USD 2000View Report
  • Investigation Report on China Capecitabine Market, 2010-2019

    Jun 2015

    By

    Pages

    Capecitabine, developed by F. Hoffmann-La Roche Ltd, entered the markets in the US, Canada and Sweden in 1998 under the trade name of Xeloda and then spread through over 80 countries and regions in 2 years. In Mar. 2001, capecitabine entered China to be clinically used for the treatment of advanced breast cancer, colorectal cancer and other solid tumors. The chemotherapy for colorectal cancer...

    USD 2000View Report